{"id":"W2045185806","doi":"10.1038/ncprheum0959","title":"Rilonacept in cryopyrin-associated periodic syndromes: the beginning of longer-acting interleukin-1 antagonism","year":2008,"lang":"en","type":"letter","venue":"Nature Clinical Practice Rheumatology","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Anakinra; Medicine; Canakinumab; Interleukin 1 receptor antagonist; Pharmacology; Antagonist; Blockade; Clinical trial; Receptor antagonist; Internal medicine; Immunology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001579707,0.0007402478,0.002230177,0.0002771679,0.0006723487,0.001093642,0.001082651,0.01364367,0.002045827],"category_scores_gemma":[0.005236705,0.0002545723,0.0009642963,0.0002266618,0.001209442,0.002044558,0.000458107,0.01215789,0.001312539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001996293,"about_ca_system_score_gemma":0.000707874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008912461,"about_ca_topic_score_gemma":0.001877368,"domain_scores_codex":[0.999285,0.0002503833,0.0001213087,0.0000760992,0.0001633957,0.0001038038],"domain_scores_gemma":[0.9977507,0.001735498,0.00009368762,0.00007093906,0.0001475203,0.000201683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006819417,0.0004469172,0.004344004,0.0009289529,0.0002681385,0.1266959,0.0003159649,0.001235403,0.00680826,0.01517139,0.6604131,0.1765526],"study_design_scores_gemma":[0.01441888,0.003139146,0.01119964,0.001046968,0.0003924787,0.1036979,0.0003715549,0.00723423,0.005922202,0.03777733,0.8145363,0.0002633372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.02713729,0.05273875,0.002144948,0.8680134,0.034698,0.00009980315,0.0002201659,0.0002544837,0.01469321],"genre_scores_gemma":[0.2390872,0.03799273,0.003822335,0.5165906,0.1780045,0.0003031088,0.000243172,0.0001250724,0.02383141],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01364367,"threshold_uncertainty_score":0.01448417,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02092049039099148,"score_gpt":0.3411310126030737,"score_spread":0.3202105222120822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}